Search Browse Earnings

Azitra, Inc.

NYSE:AZTR

Pharmaceutical Preparations·BRANFORD, CT

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Azitra, Inc. — SlamSEC

Revenue

$7,500

-98.9% YoY

FY 2025

Adj. EBITDA

-$10.9M

-144719.4% margin

FY 2025

Net Income

-$9.0M

-119566.6% margin

FY 2025

EPS (Diluted)

-$15.70

FY 2025

Stock Price

$0.18

+2.5%

2026-03-06

52W Range

$0.15 – $2.66

P/E Ratio

-0.0x

Market Cap

$2.9M

Cash

$4.6M

FY 2025

Total Debt

—

Net Cash

$4.6M

FY 2025

Enterprise Value

-$1.6M

Debt / EBITDA

0.4x

FY 2025

EV / EBITDA

0.2x

Employees

—

CEO

Salva Francisco D.

CFO

Staskey Norm